Advertisement
The leader in healthcare business news, research & data

Pharmaceuticals

Generic-drug approval growth doesn't spark competition

Generic-drug approval growth doesn't spark competition

The first three generics introduced make the biggest dent on prices. But the vast majority of generic-drug approvals from 2012 to 2017 were for the fourth, fifth, sixth or even later versions that minimally impact prices, according to a new report.

Week Ahead: HIMSS19, here we come

Week Ahead: HIMSS19, here we come

The latest and greatest health IT innovations will be on display among the nearly 1,200 vendors. Top level HHS officials, including Alex Azar, Seema Verma and Dr. Donald Rucker, are scheduled to speak.

Advertisement
X

Subscribe and SAVE 50%

View our best offer
Subscribe to Print